Targeting KRAS in Pancreatic Cancer: What is Daraxonrasib’s Mechanism of Action?ByAsfar Azmi, PhDApril 30th 2026Asfar Azmi, PhD, discusses the tricomplex mechanism of daraxonrasib and its impact on overall survival for patients with pancreatic cancer.